WHO Raises Warning Over Severe Shortage of Weight-Loss Jabs
Less than a tenth of people who could benefit from obesity jabs including Wegovy have access to them, warns the WHO as it issues its inaugural guidance on the drugs.
With in excess of 1,000,000,000 individuals worldwide currently obese, it is advocating for broader and more equitable access to this class of drugs.
Based on projections, more than two billion could be living with obesity by 2030 if no action is taken.
"Our latest guidance acknowledges that excess weight is a long-term condition that can be treated with holistic and lifelong treatment," remarked WHO director-general Tedros Adhanom Ghebreyesus.
High costs, limited production capacity, and distribution challenges are major barriers to broad availability to the injections that can aid individuals in losing significant body mass, says the body.
Skinny Jab Scarcity
Even under the present most optimistic case, the production of GLP-1 therapies might only reach around 100 million people – fewer than 10% of those who need them, as stated by the health organization.
The guideline urges governments and firms to widen availability, via measures such as patent sharing.
Exclusive production rights on the active ingredient – the primary component of the drug Wegovy – is due to expire in a number of countries in 2026.
How Obesity Injections Operate
The injections mimick a natural hormone to reduce digestion speed, reduce hunger and increase feelings of fullness so individuals reduce food intake.
Patients typically begin shedding pounds in the initial weeks of starting on the weekly injections.
Studies points to patients may put most of the weight back on a year later of halting the medication, when their usual food cravings return.
Being above a healthy weight increases your chance for experiencing medical conditions, including type 2 diabetes, heart disease, stroke, and some malignancies.
Excess weight impacts individuals in every country and was associated with millions of fatalities worldwide in 2024, per the WHO.
